Last reviewed · How we verify
Oral contraceptives--ethinyl estradiol, levonorgestrel — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Oral contraceptives--ethinyl estradiol, levonorgestrel (Oral contraceptives--ethinyl estradiol, levonorgestrel) — FHI 360.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oral contraceptives--ethinyl estradiol, levonorgestrel TARGET | Oral contraceptives--ethinyl estradiol, levonorgestrel | FHI 360 | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oral contraceptives--ethinyl estradiol, levonorgestrel CI watch — RSS
- Oral contraceptives--ethinyl estradiol, levonorgestrel CI watch — Atom
- Oral contraceptives--ethinyl estradiol, levonorgestrel CI watch — JSON
- Oral contraceptives--ethinyl estradiol, levonorgestrel alone — RSS
Cite this brief
Drug Landscape (2026). Oral contraceptives--ethinyl estradiol, levonorgestrel — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-contraceptives-ethinyl-estradiol-levonorgestrel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab